As of 2024-07-27, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (15.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.39 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -752.6%.
The range of the Relative Valuation is (16.49) - (16.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 23.8x - 30.1x | 27.0x |
| Fair Price | (16.49) - (16.12) | (15.60) |
| Upside | -790.1% - -774.4% | -752.6% |
| Date | P/E |
| 2024-07-26 | -4.46 |
| 2024-07-25 | -4.35 |
| 2024-07-24 | -4.05 |
| 2024-07-23 | -4.15 |
| 2024-07-22 | -3.94 |
| 2024-07-19 | -3.72 |
| 2024-07-18 | -3.90 |
| 2024-07-17 | -3.98 |
| 2024-07-16 | -4.16 |
| 2024-07-15 | -3.96 |
| 2024-07-12 | -3.70 |
| 2024-07-11 | -3.47 |
| 2024-07-10 | -3.04 |
| 2024-07-09 | -2.99 |
| 2024-07-08 | -2.99 |
| 2024-07-05 | -3.12 |
| 2024-07-03 | -3.10 |
| 2024-07-02 | -2.99 |
| 2024-07-01 | -3.13 |
| 2024-06-28 | -3.14 |
| 2024-06-27 | -3.25 |
| 2024-06-26 | -3.14 |
| 2024-06-25 | -3.17 |
| 2024-06-24 | -3.38 |
| 2024-06-21 | -3.45 |
| 2024-06-20 | -3.27 |
| 2024-06-18 | -3.27 |
| 2024-06-17 | -3.21 |
| 2024-06-14 | -3.40 |
| 2024-06-13 | -3.42 |
| 2024-06-12 | -3.57 |
| 2024-06-11 | -3.60 |
| 2024-06-10 | -3.55 |
| 2024-06-07 | -3.27 |
| 2024-06-06 | -3.27 |
| 2024-06-05 | -3.62 |
| 2024-06-04 | -3.29 |
| 2024-06-03 | -3.27 |
| 2024-05-31 | -3.17 |
| 2024-05-30 | -3.17 |
| 2024-05-29 | -3.06 |
| 2024-05-28 | -3.16 |
| 2024-05-24 | -3.03 |
| 2024-05-23 | -3.01 |
| 2024-05-22 | -3.12 |
| 2024-05-21 | -3.12 |
| 2024-05-20 | -3.31 |
| 2024-05-17 | -3.31 |
| 2024-05-16 | -3.44 |
| 2024-05-15 | -3.62 |